Chongqing Zhifei Biological Products Co Ltd Class A 300122
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 300122 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CNY 35.70
- Day Range
- CNY 35.01–35.85
- 52-Week Range
- CNY 33.51–70.27
- Bid/Ask
- CNY 35.09 / CNY 35.10
- Market Cap
- CNY 84.02 Bil
- Volume/Avg
- 20.6 Mil / 20.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 11.39
- Price/Sales
- 1.58
- Dividend Yield (Trailing)
- 1.42%
- Dividend Yield (Forward)
- 1.42%
- Total Yield
- 1.42%
Company Profile
Chongqing Zhifei Biological Products Co Ltd is a biotech company. It is a Chinese firm and engaged in the research and development, production, Distribution and import and export and sale of vaccines.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Large Core
- Total Number of Employees
- 6,545
- Website
- http://www.zhifeishengwu.com
Comparables
Valuation
|
Metric
|
300122
|
688319
|
301207
|
|---|---|---|---|
Price/Earnings (Normalized) | 11.39 | 382.35 | 18.19 |
Price/Book Value | 2.58 | 4.13 | 2.09 |
Price/Sales | 1.58 | 7.38 | 5.76 |
Price/Cash Flow | 14.61 | 310.43 | 16.73 |
Price/Earnings
300122
688319
301207
Financial Strength
|
Metric
|
300122
|
688319
|
301207
|
|---|---|---|---|
Quick Ratio | 1.69 | 2.07 | — |
Current Ratio | 2.26 | 2.27 | — |
Interest Coverage | 143.35 | 4.42 | — |
Quick Ratio
300122
688319
301207
Profitability
|
Metric
|
300122
|
688319
|
301207
|
|---|---|---|---|
Return on Assets (Normalized) | 15.03% | −0.41% | 9.39% |
Return on Equity (Normalized) | 24.78% | −0.68% | 11.86% |
Return on Invested Capital (Normalized) | 21.96% | −0.17% | 11.24% |
Return on Assets
300122
688319
301207
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Clznxrmqj | Nfyh | $570.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Ryrmwdhq | Yxlrpb | $103.9 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Clwddfpk | Jccjv | $99.6 Bil | |
MRNA
| Moderna Inc | Hfqtshsp | Jqbl | $42.7 Bil | |
ARGX
| argenx SE ADR | Qqndttjyh | Qyr | $22.2 Bil | |
BNTX
| BioNTech SE ADR | Rydtwrtc | Stvl | $21.7 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Lsgqhxbx | Mwcjp | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Pymqcyrv | Bzjdzx | $15.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Vjyplkgzch | Ylsjgg | $12.7 Bil | |
INCY
| Incyte Corp | Vnhwyqjt | Gcctbb | $11.9 Bil |